Finally, Nrg4 transgenic mice significantly improved lipid metabolism disorders and hepatic steatosis, supporting the potential therapeutic role of Nrg4 in NAFLD (Wang et al., 2014). This evidence concerns the gene NRG4 and metabolic dysfunction-associated steatotic liver disease.